CAS 115956-12-2
:Dolasétron
Description :
Dolasetron is an antagonist of the serotonin (5-HT) receptor subtype 5-HT
3
(K
i
= 20 nM).
1
It is selective for 5-HT
3
receptors over 5-HT
1A
, 5-HT
1B
, 5-HT
2
, dopamine D
2
, α
1
-, α
2
-, β-adrenergic, M
1-5
muscarinic acetylcholine, and neurokinin-1 (NK
1
) receptors (IC
50
s = >10 μM for all).
2
Dolasetron inhibits 5-HT-induced membrane currents in NG 108-15 cells (IC
50
= 3.8 nM).
1
It increases the latency to emesis and reduces the number of vomiting and retching episodes induced by cisplatin (Item No.
13119
) in ferrets when administered at doses of 0.5 or 2 mg/kg.
2
Formulations containing dolasetron have been used in the prevention of postoperative or chemotherapy-induced nausea.
Formule :C19H20N2O3
InChI :InChI=1/C19H20N2O3/c22-17-10-21-13-5-12(17)6-14(21)8-15(7-13)24-19(23)18-16-4-2-1-3-11(16)9-20-18/h1-4,12-15H,5-10H2
Code InChI :InChIKey=UKTAZPQNNNJVKR-MMUVGSQPNA-N
SMILES :O(C(=O)C=1C=2C(NC1)=CC=CC2)[C@@H]3C[C@]4([N@]5[C@](CC(C4)C(=O)C5)(C3)[H])[H]
Synonymes :- (2alpha,6alpha,8alpha,9abeta)-Octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl-1H-indole-3-carboxylate
- (6R)-3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate
- 1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, (2α,6α,8α,9aβ)-
- 1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, stereoisomer
- 1H-indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester
- 2,6-Methano-2H-quinolizine, 1H-indole-3-carboxylic acid deriv.
- 3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate
- 3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-isoindole-3-carboxylate
- Anemet
- Mdl 73147
- Dolasetron
- 1H-Indole-3-carboxylicacid, octahydro-3-oxo-2,6-Methano-2H-quinolizin-8-yl ester, stereoisoMer
- Dolasteron
- Unii-82wi2L7Q6e
- 1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, (2alpha,6alpha,8alpha,9abeta)-
- Octahydro-3-oxo-2,6-Methano-2H-quinolizin-8-yl Ester
- rel-(5s,6R,8r,9aS)-3-Oxooctahydro-1H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate
- 1H-Indole-3-carboxylic Acid 3-Oxooctahydro-2H-2,6-methanoquinolizin-8-yl Ester
- Hsdb 7565
- dolasetron USP/EP/BP
- Dolasetronum [inn-latin]
- (2a,6a,8a,9ab)-1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester
- Dolasetronum
- Voir plus de synonymes
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
13 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
Dolasetron
CAS :Formule :C19H20N2O3Degré de pureté :>98.0%(HPLC)Couleur et forme :White to Almost white powder to crystalineMasse moléculaire :324.38Dolasteron
CAS :DolasteronFormule :C19H20N2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :324.37Dolasetron-d4 (Indole-d4)
CAS :Formule :C19H16D4N2O3Couleur et forme :Off-White SolidMasse moléculaire :328.40Dolasetron
CAS :Formule :C19H20N2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :324.3737Dolasetron
CAS :Produit contrôléApplications Bridged pseudopelletierine derivative; specific serotonin (5HT3) receptor antagonist. Antiemetic.
References Boeijinga, P.H., et al.: Eur. J. Pharmacol., 219, 9 (1992), Miller, R.C., et al., Drug Dev. Res., 28, 87 (1993), Fauser, A.A., et al.: Eur. J. Cancer, 32, 1523 (1996), Graczyk, S.G., et al.: Anesth. Analg., 84, 325 (1997),Formule :C19H20N2O3Couleur et forme :NeatMasse moléculaire :324.37Dolasetron
CAS :Dolasetron (MDL-73147)(MDL-73147) is a serotonin 5-HT3 receptor antagonist. Dolasetron is used to treat nausea and vomiting following chemotherapy.Formule :C19H20N2O3Degré de pureté :99.84% - 99.86%Couleur et forme :SolidMasse moléculaire :324.3737Dolasetron
CAS :rel-(5s,6R,8r,9aS)-3-Oxooctahydro-1H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylateFormule :C19H20N2O3Degré de pureté :98%Masse moléculaire :324.37Octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester
CAS :Dolasetron mesylate is a mesylate of the biologically active form of dolasetron, which is an octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester. Dolasetron has been shown to be effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy or radiation therapy. It has been approved for use in adults with cancer who have not responded to other treatments. Dolasetron is rapidly absorbed from the gastrointestinal tract and is then distributed throughout the body, including into the brain. The elimination half life of dolasetron mesylate is about 2 hours and it binds to plasma proteins. Dolasetron mesylate specifically binds to serotonin receptors, which are found on cells in the gut. This binding inhibits serotonin induced contraction of bowel smooth muscle cells.Formule :C19H20N2O3Degré de pureté :Min. 95%Couleur et forme :White To Off-White To Grey SolidMasse moléculaire :324.37 g/mol










